Product Reports Resources Pricing Login Book a demo

Rakuten Medical

Biotech & Life Sciences · San Mateo, United States · Founded 2010

Developing precision cancer therapies using an investigational photoimmunotherapy platform to improve targeted treatment outcomes MoreLess

Rakuten Medical is a biotechnology startup that operates in the healthcare industry, specifically in the field of cancer treatment. The company is developing a unique platform called Alluminox™, which is based on a cancer therapy known as photoimmunotherapy. This therapy was originally developed by Dr. Hisataka Kobayashi and his team from the National Cancer Institute in the United States.

The Alluminox™ platform is an investigational technology that includes a drug, a device, and other related components. Rakuten Medical's primary goal is to bring to market drugs and devices that treat various types of cancer using this platform. The company's mission is to provide an alternative solution in the fight against cancer, with the ultimate goal of conquering the disease.

Rakuten Medical aims to build a sustainable healthcare ecosystem that offers patients, regardless of their nationality or wealth, access to better cancer treatments. The company is committed to continuous innovation in order to develop and commercialize pioneering cancer treatments.

The business model of Rakuten Medical is based on the development and commercialization of its Alluminox™ platform. The company generates revenue by selling its innovative cancer treatment products to healthcare providers and patients.

Keywords: Rakuten Medical, biotechnology, healthcare, cancer treatment, Alluminox™ platform, photoimmunotherapy, drug development, device development, healthcare ecosystem, cancer research.

Company overview

Rakuten Medical company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2010
Headquarters
San Mateo, United States
Employees
131
Open positions
7
Dealroom signal
78.6
Investment activity
1 companies · latest Sep 2020
Capital deployed
Preferred round
ACQUISITION
client focusb2bsub industryBioTechnologysub industryMedical Devicesbusiness modelManufacturingindustryHealthsectorBiotechnologysectorOncologysectorSpinoutsectorBiotech and PharmasectorDT and LSsectorscience-based

Valuation & funding

Rakuten Medical funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VCOther financing Apr 2026 $0 Lotte
CONVERTIBLEOther financing Jan 2026 $30M Undisclosed
SERIES FOther financing Jan 2026 $70M $595M Undisclosed
SERIES EOther financing Mar 2024 $119M $476M Rakuten · Dai-ichi Life Insurance · SBI Group · Mizuho Capital
CONVERTIBLEOther financing Jan 2023 $70M Undisclosed
CONVERTIBLEOther financing Jul 2021 SBI Group · Rakuten Capital · General Catalyst
SERIES DOther financing Jul 2021 SBI Group · Rakuten Capital · General Catalyst
SERIES COther financing Aug 2019 Rakuten
SERIES COther financing Dec 2018 Rakuten · SBI Group · SBI Investment
SERIES COther financing Aug 2018 Rakuten
Showing 10 recorded eventsUnlock the complete deal history →

Growth signals

Rakuten Medical website traffic

Latest recorded traffic for Rakuten Medical is 13K monthly website visits, down 7.1% over the last three months. Rakuten Medical's team grew 6.5% over the past year.

Latest monthly visits13K 3-month web change-7.1% 1-year team growth+6.5%
Monthly website visits104 observations · Oct 2017–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Rakuten Medical compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Capital deployed

Rakuten Medical investments and acquisitions

Recent portfolio relationships for companies that also act as investors or acquirers.

Talent graph

Rakuten Medical's talent

Book a demo to see the people
Team profiled 10 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

10 investors on Rakuten Medical's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Series A 3 investors entered at this stage
Rakuten
Rakuten Capital
General Catalyst
Series B+ 6 investors entered at this stage
SBI Group
SBI Investment
Dai-ichi Life Insurance
Mizuho Capital
Hikma Pharmaceuticals
Lotte
Other known 1 additional known investor
National Cancer Institute (NCI)

Global footprint

Where Rakuten Medical has talent and traffic

Workforce by country
6 countries with
team presence
🇺🇸 United States40%
🇯🇵 Japan40%
🇹🇼 Taiwan13.8%
🇮🇳 India3.8%
🇨🇭 Switzerland1.3%
Top 5 of 6 shown

In the news

Latest news about Rakuten Medical

Recent press, funding announcements, and product moves mentioning Rakuten Medical — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Rakuten Medical

An AI-synthesized read of the highest-engagement posts about Rakuten Medical on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Rakuten Medical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.